Cardiovascular disease

A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer to human trials, thanks to a $23 million investment in a Brisbane start-up.

The SARS-CoV-2 virus does not infect blood vessels, despite the high risk of blood clots, IMB researchers have confirmed.

It might be one of the most feared arachnids in the world, but research shows the deadly funnel web spider could make the difference between life and death for heart attack victims. 

A potentially life-saving treatment - Hi1a - for heart attack victims has been discovered from the venom of the Fraser Island funnel web spider.

Finding decision-making genes has implications for blocking a cell’s bad decisions when things go wrong in disease or in the environment.

Four IMB women will share how they are tackling big problems such as obesity and cardiovascular disease, stroke, spinal cord injuries and sheep parasites through the Queensland Women in STEM competition.

IMB researcher Dr Sam Lukowski has helped reveal the difference between a stem cell and other blood vessels.

Voting has opened for this year's Queensland Women in STEM Prize.

A project using molecules from spider venom to develop improved treatments for chronic pain and stroke will be undertaken by Institute for Molecular Bioscience (IMB) Professor Glenn King in partnership with University of Science and Technology of China, after receiving funding from the Queensland Government.